top of page
molecule of psychedelics.jpg

Current Studies

Reverie is committed to providing patients with access to currently approved treatment options and being a part of researching and studying new therapies. Reverie's studies are reviewed by an ethics committee and comply with Food and Drug Administration guidelines and regulations.

manwiththerapist_OUD_Reverie

01

Schizophrenia

This study is for patients who are experiencing schizophrenia. Reverie is working with a company to validate a technology tool with medication to help individuals with schizophrenia that provides greater and potentially beneficial support to patients.

02

Major Depressive Disorder 

Reverie is working with a company to further evaluate their therapy for patients who have a major depressive disorder (MDD). No insurance is required.

women_depression_reverieMDD

03

Postpartum Depression (PPD)

Reverie is working with a company to further evaluate their therapy for patients who are experiencing postpartum depression. No insurance is required.

Postpartum_Blog.png
bottom of page